Couple of more interesting things... "The additional

New Post Public Reply Private Reply Replies (2) Message Board
redspeed
473
Couple of more interesting things...

"The additional revenue from the newly introduced sales enablement applications, and the revenue we expect to generate from our new verticals, including MARKET, together with a new pricing model we’re about to introduce to our direct sales clients that will better align our interests with theirs creating a true win/win , coupled with these continuing cost reductions, give us confidence in our ability to achieve positive EBITDA and reduce our reliance on the capital markets."

So what's the new pricing model?

One model one of Verb's partners use it Licensing based on Revenue

https://www.directscale.com/pricing/

Don't know if that is the model, but it's one way of having interest aligned.

It's like that Fisher Investment commercial I hear on the radio...

"Simply put, when you do better we do better."

https://www.youtube.com/watch?v=hT4EIwJJOUQ&a...nvestments

Fisher Investment seems much better than what some have described as the financial terrorists on the other site


About "achieve positive EBITDA".

I've been very impressed with how hard Verb has worked to cut cost. They could have hired a bunch of people just to ensure the success of Market launch was a guaranteed success and be paying for it for months/years to come. They didn't.

In fact the 4 Market jobs are still open. Verb was able to pull it off without the extra hands. Getting to positive EBITDA sooner than later can only be a good thing and use capital markets to expand quicker like almost all tech companies including Salesforce.

https://www.verb.tech/careers





TON Strategy Co. (TONX) Stock Research Links

TONX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Gnosis Lab's Grand Re-Opening: A New Era for Diagnostics

Updated Category News Views 260

Gnosis Lab Grand Re-Opening Celebration Gnosis, a modern diagnostic laboratory previously known as Mountain View Medical Laboratory, is excited to announce its grand re-opening at its flagship location. This event signifies a crucial transition for the lab as it seeks to blend years of reliable community service with a fresh identity and enhanced capabilities. Commitment...

Continue Reading
New Propane Contract Boosts Titan NRG (TTNN) Growth

Updated Category Stocks Views 404

Titan NRG, Inc. Announces Major Propane Contract Secured Titan NRG, Inc. (OTC: TTNN) has a big contract for the 150,000 gallons of propane supply. Given to one of its subsidiaries, this contract represents a significant turning point for the business. Under this contract, propane will be delivered over the next year to a southern Arizona reservation. Crucially in securing...

Continue Reading
Bitcoin Price Decline: Impact of DOJ and Economic Conditions

Updated Category News Views 259

Bitcoin Price Experiences a Notable Decline Bitcoin has recently faced a serious downturn, falling to around $93,925 as fears surrounding U.S. interest rate changes and potential government sales of Bitcoin emerged. This has created a concerning environment for cryptocurrency investors, highlighting the volatility of digital assets. Market Sentiment and Economic Shifts...

Continue Reading
Cogitate and One Inc Team Up to Revolutionize Payments

Updated Category News Views 169

Cogitate Partners with One Inc to Transform Digital Payments -Customers Enjoy a Seamless Experience by Unifying All Payment Flows into One Comprehensive Platform- Cogitate, a provider of cloud-native core policy, billing, and claims applications for insurers, is excited to announce its partnership with One Inc, the leading digital payments network specifically for the...

Continue Reading
Alnylam Pharmaceuticals Achieves New Stock Milestone of $287.88

Updated Category News Views 74

Alnylam Pharmaceuticals Reaches Record Stock Price Alnylam Pharmaceuticals Inc. has recently made headlines after its stock price reached a remarkable all-time high of $287.88. This surge demonstrates a substantial increase in investor confidence, bolstered by an impressive 1-year change of 71.84% in the company's stock. Known for its groundbreaking work in RNA...

Continue Reading